Urging the centre to include the Huntington’s disease (HD), an inherited genetic disease that causes nerve cells in the brain ...

Bayer has agreed to acquire Perfuse Therapeutics for up to $2.45 billion, in a deal designed to broaden the buyer’s ophthalmology pipeline with Perfuse’s sole pipeline drug and two clinical phase ...

Prospective parents can now pick embryos based on risk predictions for thousands of diseases and odds for specific traits.

Both MI and LSG have the least number of wins in their account this season, with just two wins each in nine and eight matches ...

When I arrived in Poland, my goal was clear, to better understand the health and genetic conditions affecting the Karaite ...

STARKVILLE — Mississippi State University biologist Matthew W. Brown is part of an international research team whose latest findings, published this spring in the Proceedings of the National Academy o ...

8 min read | April 2026 showed us a toxic HTT fragment is center stage in mouse research, CRISPR is showing promise in mouse ...

We were pleased with Regeneron's performance to start 2026, highlighted by strong commercial execution across our key growth products, continued pipeline progress, a disciplined approach to capital ...

FARGO — The Northern Plains chapter of the Huntington's Disease Society of America will hold a Team Hope Walk fundraiser and ...

Today, those deals include a viral K-beauty serum loaded with salmon DNA (seriously!), a handheld vacuum cleaner from ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...